Related Experiment Video
Updated: Sep 19, 2025

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
Published on: May 11, 2018
Ventricular assist devices in functionally univentricular hearts.
Maruti Haranal1, Thakut Gowtham1
1Department of Pediatric Cardiac Surgery, U N Mehta Institute of Cardiology and Research Ahmedabad, Gujarat, 380016 India.
Survival rates for single ventricle heart patients are improving, leading to more complex cases. Mechanical circulatory support, like ventricular assist devices, is increasingly vital for heart transplantation in these patients, despite implantation challenges.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Surgery
- Mechanical Circulatory Support
Background:
- Improved surgical techniques and perioperative care have increased survival rates for patients with functionally univentricular hearts.
- A growing number of single ventricle patients are developing end-stage heart failure, necessitating advanced treatment options.
- Donor heart scarcity highlights the need for mechanical circulatory support as a bridge to heart transplantation.
Purpose of the Study:
- To review the evolution and current applications of ventricular assist devices (VADs) in patients with single ventricle physiology.
- To analyze the challenges and outcomes associated with VAD implantation in this unique patient population.
Main Methods:
- Literature review focusing on the use of VADs in functionally univentricular hearts.
- Analysis of existing data on implantation techniques, patient selection, and outcomes.
- Examination of the anatomical and physiological considerations specific to this patient group.
Main Results:
- VADs play a crucial role in supporting failing myocardium and improving systemic perfusion and oxygenation.
- Implantation of VADs in single ventricle patients presents unique anatomical and physiological challenges.
- Evidence supports the use of VADs in a subset of patients with functionally univentricular hearts.
Conclusions:
- Ventricular assist devices are becoming an essential therapeutic option for single ventricle patients with end-stage heart failure awaiting transplantation.
- Further research and technological advancements are needed to optimize VAD therapy in this complex population.
- Addressing the specific challenges of VAD implantation is critical for improving outcomes in functionally univentricular hearts.
More Related Videos
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Heart Failure VI: Adjunct Therapies
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure Drugs: Inotropic Agents
Heart Valves
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
Chambers of the Heart
Deoxygenated blood from the body is received in the right...

